CompletedPhase 1

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

Nigeria140 participantsStarted 2015-09

Plain-language summary

Randomized controlled single blind prospective comparative study

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant HIV positive patients, * Gestational age 16 weeks and above, * No history of azithromycin or sulphadoxine-pyrimethamine use four weeks prior to recruitment Exclusion Criteria: * Anaemia packed cell volume less than 30%, * pre-existing medical conditions- diabetes mellitus, * hypertension, * allergy to sulphadoxine-pyrimethamine or azithromycin

What they're measuring

Level of malaria parasitemia at delivery in HIV positive women following administration of Azithromycin or Sulphadoxine- pyrimethamine as intermittent preventive therapy for malaria in pregnancy

Timeframe: 6 months

Trial details

NCT IDNCT02527005

SponsorUniversity of Ibadan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-08

View on ClinicalTrials.gov More Malaria trials